𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Increased frequency of a mutation in coagulation factor V associated with resistance to activated protein C in patients with coronary artery disease

✍ Scribed by M. Chen; H. Seydewitz; B. Winckelmann; M. Nauck; H. Wieland; L. Witt; W. März

Book ID
118325992
Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
105 KB
Volume
115
Category
Article
ISSN
0021-9150

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evidence against heterozygous coagulatio
Evidence against heterozygous coagulation factor V 1691 G→A mutation with resistance to activated protein C being a risk factor for coronary artery disease and myocardial infarction
✍ W. Prohaska; H. Mannebach; M. Schmidt; U. Gleichmann; K. Kleesiek 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 327 KB

The aim of our study was to determine the prevalence of the factor V mutation (position 1691 G->A) in patients with angiographically diagnosed coronary artery disease and myocardial infarction and, as a control, in blood donors. This mutation has already been proved to be the main genetic risk facto

Resistance to activated protein C due to
Resistance to activated protein C due to factor V Leiden mutation: high prevalence in patients with post-thrombotic leg ulcers
✍ Y. Gaber; H-J. Siemens; W. Schmeller 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 201 KB

## Background: Activated protein c (apc) resistance is the most frequently diagnosed heritable thrombophilic defect predisposing to thrombosis. ## Objectives: To determine the prevalence of apc resistance due to factor v leiden mutation in patients with leg ulcers. ## Methods: Within a 2-year-p